OCUGEN, INC. Public Float
OCUGEN, INC. (OCGN) had Public Float of $279.20 million as of 2025-06-30, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-04
- 2025-06-30: Entity Public Float $279.20M.
- 2024-06-30: Entity Public Float $392.90M.
- 2023-06-30: Entity Public Float $137.30M.
- 2022-06-30: Entity Public Float $483.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $279.20M 10-K · filed 2026-03-04 |
| 2024-06-30 | $392.90M 10-K · filed 2025-03-05 |
| 2023-06-30 | $137.30M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $483.20M 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.60B 10-K · filed 2022-02-28 |
| 2020-06-30 | $28.60M 10-K · filed 2021-03-19 |
| 2019-06-30 | $18.10M 10-K · filed 2020-03-27 |
| 2018-06-30 | $63.60M 10-K · filed 2019-03-22 |
| 2017-06-30 | $14.90M 10-K · filed 2018-03-15 |
| 2016-06-30 | $14.90M 10-K · filed 2017-03-16 |
| 2015-06-30 | $56.20M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |